Literature DB >> 30478763

Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.

Kazutaka Okita1, Shingo Hatakeyama2, Naoki Fujita1, Sakae Konishi1, Hayato Yamamoto1, Atsushi Imai1, Takahiro Yoneyama1, Yasuhiro Hashimoto1, Hiroyuki Ito3, Kazuaki Yoshikawa4, Takuya Koie5, Chikara Ohyama1.   

Abstract

We aimed to investigate the impact of postoperative weight loss following radical cystectomy (RC) on patients' prognoses. RC and urinary diversion were performed in 512 consecutive patients with muscle-invasive bladder cancer at our hospitals between May 1996 and July 2018. Demographic clinical information, pre- and postoperative serum albumin, hemoglobin, and weight were evaluated retrospectively at 1 month. We also evaluated the association of weight loss with complications and overall survival (OS) as estimated using the Kaplan-Meier method and compared using the log-rank test. Risk factors for poor OS were determined by Inverse Probability of Treatment Weighted (IPTW)-adjusted Cox regression analysis. In 385 patients who met the study search criteria, median postoperative weight loss from baseline at 1 week and 1 month was 1.1 (- 1.8%) and 3.2 (- 5.4%) kg, respectively. Patients with significant weight loss (defined as ≥ 7.5% at 1 month) had higher-grade complications within 1 month and had significantly shorter OS than those with weight loss of < 7.5%. Type of urinary diversion, loss of serum albumin, and loss of hemoglobin were not significantly associated with weight loss. IPTW-adjusted Cox regression analysis showed that such significant weight loss was an independent risk factor for poor OS. Weight loss followed by radical cystectomy was significantly associated with poor prognosis in patients with muscle-invasive bladder cancer.

Entities:  

Keywords:  Bladder cancer; Cystectomy; Frailty; Survival; Weight loss

Mesh:

Year:  2018        PMID: 30478763     DOI: 10.1007/s12032-018-1232-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  30 in total

1.  Time-dependent variation in weight and body composition in healthy adults.

Authors:  K Rosenbaum; J Wang; R N Pierson; D P Kotler
Journal:  JPEN J Parenter Enteral Nutr       Date:  2000 Mar-Apr       Impact factor: 4.016

2.  Prehabilitation: preparing patients for surgery.

Authors:  Venetia Wynter-Blyth; Krishna Moorthy
Journal:  BMJ       Date:  2017-08-08

3.  Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: A single-center randomized trial.

Authors:  Alvaro Vidal; Nicolas Arnold; Mihai Dorin Vartolomei; Bernhard Kiss; Fiona Burkhard; George N Thalmann; Beat Roth
Journal:  Int J Urol       Date:  2016-10-21       Impact factor: 3.369

4.  Laparoscopic intracorporeal ileal conduit after laparoscopic radical cystectomy: A modified technique to facilitate ureteroenteric anastomosis.

Authors:  Toru Kanno; Go Kobori; Noboru Shibasaki; Seiji Moroi; Toshiya Akao; Hitoshi Yamada
Journal:  Int J Urol       Date:  2018-08-26       Impact factor: 3.369

Review 5.  Prehabilitation for major abdominal urologic oncology surgery.

Authors:  Bente T Jensen; Susanne V Lauridsen; Jørgen B Jensen
Journal:  Curr Opin Urol       Date:  2018-05       Impact factor: 2.309

6.  Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy.

Authors:  Meera R Chappidi; Max Kates; Hiten D Patel; Jeffrey J Tosoian; Deborah R Kaye; Nikolai A Sopko; Danny Lascano; Jen-Jane Liu; James McKiernan; Trinity J Bivalacqua
Journal:  Urol Oncol       Date:  2016-02-15       Impact factor: 3.498

Review 7.  Diagnostic test accuracy of simple instruments for identifying frailty in community-dwelling older people: a systematic review.

Authors:  Andrew Clegg; Luke Rogers; John Young
Journal:  Age Ageing       Date:  2014-10-29       Impact factor: 10.668

8.  The Impact of Preoperative Severe Renal Insufficiency on Poor Postsurgical Oncological Prognosis in Patients with Urothelial Carcinoma.

Authors:  Masaki Momota; Shingo Hatakeyama; Noriko Tokui; Tendo Sato; Hayato Yamamoto; Yuki Tobisawa; Tohru Yoneyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Satoshi Narita; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  Eur Urol Focus       Date:  2018-03-13

9.  Nutritional predictors of complications following radical cystectomy.

Authors:  David C Johnson; Stephen B Riggs; Matthew E Nielsen; Jonathan E Matthews; Michael E Woods; Eric M Wallen; Raj S Pruthi; Angela B Smith
Journal:  World J Urol       Date:  2014-09-21       Impact factor: 4.226

10.  Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.

Authors:  Takuya Koie; Chikara Ohyama; Hayato Yamamoto; Atsushi Imai; Shingo Hatakeyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Tohru Yoneyama; Yuki Tobisawa
Journal:  Med Oncol       Date:  2014-04-04       Impact factor: 3.064

View more
  3 in total

Review 1.  Frailty as a prognostic indicator in the radical cystectomy population: a review.

Authors:  Niki Parikh; Pranav Sharma
Journal:  Int Urol Nephrol       Date:  2019-06-07       Impact factor: 2.370

2.  Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.

Authors:  Sappaya Suppanuntaroek; Shingo Hatakeyama; Naoki Fujita; Yuka Kubota; Yuichiro Suzuki; Teppei Okamoto; Yuki Tobisawa; Tohru Yoneyama; Hayato Yamamoto; Kazuyuki Mori; Atsushi Imai; Takahiro Yoneyama; Yasuhiro Hashimoto; Chikara Ohyama
Journal:  Int J Clin Oncol       Date:  2019-10-26       Impact factor: 3.402

3.  Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study).

Authors:  Hiromichi Iwamura; Shingo Hatakeyama; Masaki Momota; Yuta Kojima; Takuma Narita; Teppei Okamoto; Naoki Fujita; Itsuto Hamano; Kyou Togashi; Tomoko Hamaya; Tohru Yoneyama; Hayato Yamamoto; Takahiro Yoneyama; Yasuhiro Hashimoto; Chikara Ohyama
Journal:  Transl Androl Urol       Date:  2021-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.